AUXL Financial Facts
Total operating expenses: 132.82MWeighted average common shares outstanding: 50.4M
See Full Income Statement
Commitments and contingencies: 0
Short-term investments: 3.84M
See Full Balance Sheet
Auxilium Pharmaceuticals Inc. (AUXL) Earnings
|
Expand Research on AUXL
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | -11.6% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -4.3% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/30/14 | Q314 | $0.27 | $0.10 | +$0.17 | $109.6M | $101.02M | = | Details | |||
8/7/14 | Q214 | -$0.44 | -$0.21 | -$0.23 | $83M | $88.52M | = | Details | |||
5/5/14 | Q114 | -$0.39 | -$0.17 | -$0.22 | $8.5M | $89.2M | = | Details | |||
2/28/14 | Q413 | $0.27 | $0.22 | +$0.05 | $125.9M | $111.83M | = | Details | |||
11/6/13 | Q313 | $0.17 | $0.15 | +$0.02 | $108.1M | $103.66M | = | Details | |||
8/1/13 | Q213 | $0.02 | -$0.03 | +$0.05 | $100.5M | $91.43M | = | Details | |||
4/29/13 | Q113 | -$0.05 | $0.02 | -$0.07 | $66.2M | $81.23M | = | Details | |||
2/26/13 | Q412 | $1.83 | $1.72 | +$0.11 | $172.5M | $171.2M | = | Details |